第39卷第3期2023年3月长春中医药大学学报JournalofChangchunUniversityofChineseMedicineVol.39No.3Mar.2023—248—DOI:10.13463/j.cnki.cczyy.2023.03.004从“正邪不争”角度探讨新冠肺炎患者核酸检测持续阳性机理及治疗徐佳男1，侯安琪1，王子元1，王科举1，李振宇1，李安冬1，王檀2*（1.长春中医药大学，长春130117；2.长春中医药大学附属医院，长春130021）摘要：长春中医药大学附属医院COVID-19救治专家组针对2022年春吉林省新一轮疫情制定了防控方案，并首次提出部分新冠肺炎患者核酸检测持续阳性问题的治疗策略。本次吉林省疫情属“寒湿疫”范畴，“正邪不争”为患者核酸久不转阴的关键，虚处藏奸，正邪缠绵、相持，导致寒湿疫邪留连不去。具体表现根据感染个体情况发生从化，热化者多为发热过后，气阴两伤，络气不和，寒化者多见脾肾虚冷，疫毒伤络。治疗上扶正与祛邪并举，攻补兼施，寒温并用，借正邪相争之机祛邪外出。关键词：新冠肺炎；核酸持续阳性；寒湿疫；正气；邪气中图分类号：R254.3文献标志码：A文章编号：2095-6258(2023)03-0248-04DiscussiononthemechanismandtreatmentofpersistentpositivenucleicacidtestDiscussiononthemechanismandtreatmentofpersistentpositivenucleicacidtestresultsinpatientswithCOVID-19fromtheperspectiveof"nostrugglesbetweenresultsinpatientswithCOVID-19fromtheperspectiveof"nostrugglesbetweenvitalqiandpathogenicqi"vitalqiandpathogenicqi"XUJianan1,HOUAnqi1,WANGZiyuan1,WANGKeju1,LIZhenyu1,LIAndong1,WANGTan2*(1.ChangchunUniversityofChineseMedicine,Changchun130117,China;2.AffiliatedHospitalofChangchunUniversityofChineseMedicine,Changchun130021,China)Abstract:Abstract:TheCOVID-19treatmentexpertgroupoftheAffiliatedHospitalofChangchunUniversityofChineseMedicineformulatedapreventionandcontrolplanforthenewroundofepidemicinJilinProvinceinthespringof2022,andputforwardatreatmentstrategyforthepersistentpositivenucleicacidtestresultsinsomepatientswithCOVID-19.ItisbelievedthatthiswaveofepidemicinJilinProvincebelongstothecategoryof"cold-damppestilence"intraditionalChinesemedicine,and"nostrugglesbetweenvitalqiandpathogenicqi"isthekeytothepatients'nucleicacidtestresultsnotturningnegativeforalongtime.Specificmanifestationsofaf...
